2-es típusú cukorbetegség: vizsgálatok itt: Bulgária
10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleAMBITION 3: A research study investigating how well zenagamtide at higher dose levels lowers blood sugar and body weight compared to semaglutide in people with type 2 diabetes treated with metformin, SGLT2i, or both
- Where
- Gabrovo, Ruse, Sliven, Smolyan, Sofia, Varna
- Életkor
- 18 év and over
- People
- 595 worldwide
- Run by
- Novo Nordisk A/S
See details and how to join2026-525472-26-00 · EU 2026-525472-26-00 - 3. fázisTaking peopleAMBITION 4: A research study investigating how well zenagamtide at lower dose levels lowers blood sugar and body weight compared to semaglutide at lower dose levels in people with type 2 diabetes treated with metformin, SGLT2i, or both
- Where
- Blagoevgrad, Burgas, Pazardzhik, Pleven, Sofia, Stara Zagora
- Életkor
- 18 év and over
- People
- 245 worldwide
- Run by
- Novo Nordisk A/S
See details and how to join2026-525474-20-00 · EU 2026-525474-20-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Montana, Pleven, Plovdiv, Sofia, Varna, Yambol
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - 3. fázisTaking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Dimitrovgrad, Dupnitsa, Gabrovo, Kyustendil, Pernik, Pleven, Plovdiv, Sofia, Sofiya, Stara Zagora, Yambol
- Életkor
- 18 év and over
- People
- 11 800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - 3. fázisTaking peopleA Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Where
- Plovdiv, Sofia, Sofiya, Yambol
- Életkor
- 18 év and over
- People
- 1200 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662213 · EU 2025-523933-24-00 - 3. fázisTaking peopleA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Where
- Burgas, Kazanlak, Kyustendil, Pleven, Plovdiv, Sofia, Sofiya, Stara Zagora, Varna, Veliko Tirnovo
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Where
- Dupnitsa, Haskovo, Kyustendil, Pleven, Plovdiv, Ruse, Stara Zagora, Varna
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00 - 3. fázisTaking peopleAMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Where
- Burgas, Dimitrovgrad, Dobrich, Dupnitsa, Plovdiv, Smolyan, Sofia, Stara Zagora, Yambol
- Életkor
- 45 év and over
- People
- 1778 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07797335 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- Where
- Dupnitsa, Kozloduy, Plovdiv, Sofia, Stara Zagora, Veliko Tirnovo, Yambol
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07664553 · EU 2025-523935-20-00 - 2. fázisTaking peopleA Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
- Where
- Bankya, Kozloduy, Smolyan, Sofia, Sofiya, Varna
- Életkor
- 18 év and over
- People
- 465 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00